You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 25, 2024

SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Spironolactone And Hydrochlorothiazide patents expire, and what generic alternatives are available?

Spironolactone And Hydrochlorothiazide is a drug marketed by Ascot, Chartwell Rx, Mutual Pharm, Mylan, Purepac Pharm, Sun Pharm Industries, Superpharm, and Watson Labs. and is included in eight NDAs.

The generic ingredient in SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; spironolactone. There are thirty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; spironolactone profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE?
  • What are the global sales for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE?
  • What is Average Wholesale Price for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE?
Summary for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Recent Clinical Trials for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chiang Mai UniversityPhase 3
Medical University of BialystokN/A
Shanghai Jiao Tong University School of MedicinePhase 4

See all SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE clinical trials

Pharmacology for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Drug ClassAldosterone Antagonist
Thiazide Diuretic
Mechanism of ActionAldosterone Antagonists
Physiological EffectIncreased Diuresis

US Patents and Regulatory Information for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ascot SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 088025-001 Nov 23, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Superpharm SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 089137-001 Aug 26, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 086513-001 Approved Prior to Jan 1, 1982 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087398-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.